General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Share overview

Novartis ordinary shares

ISIN CH0012005267
Bloomberg symbol NOVN VX
Reuters NOVN.VX
Currency CHF
Par value 0.5
Primary exchange SIX SWISS EXCHANGE
Index inclusions (selection) Swiss Market Index SMI®, Swiss Performance Index SPI®, Swiss Leader Index SLI®, STOXX® Europe 50, FTSE Eurotop 100 Index, Bloomberg European 500 Index, Dow Jones Global Titans 50TM Index, S&P Global 100, MSCI World Index

Novartis ADR

ISIN US66987V1098
Bloomberg symbol NVS US
Reuters NVS
Currency USD
Primary exchange NEW YORK STOCK EXCHANGE
Index inclusions (selection) S&P ADR Index, NYSE Composite Index®, NYSE Arca Pharmaceutical Index, NYSE Arca International Market Index
Stock chart